Noranda Income Fund Announces Third Quarter 2022 Results
Noranda Income Fund
Noranda Income Fund

TORONTO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Noranda Income Fund (TSX:NIF.UN) (the “Fund”) today reported its financial results for the third quarter ended September 30, 2022. Except where otherwise indicated, all amounts in this press release are expressed in US dollars.

Third Quarter 2022 Highlights (compared to same period in 2021)

  • Loss before income taxes of $16.9 million, including an unrealized derivative financial instrument loss of $33.4 million and an impairment of non-financial assets of $30.0 million, compared to earnings before income taxes of $5.9 million, including an unrealized derivative financial instrument loss of $0.1 million

  • Adjusted EBITDA1 of $40.4 million, compared to $7.8 million

  • Zinc metal production of 53,003 tonnes, compared to 64,063 tonnes

  • Zinc metal sales of 54,235 tonnes, compared to 63,676 tonnes

“Our third quarter results for 2022 reflect the ongoing operational challenges we are facing, resulting in lower zinc production and sales. Positive market conditions, such as strong zinc prices and treatment charges, helped generate strong Adjusted EBITDA performance year over year. In addition to low production volumes, our earnings were also negatively impacted by a high unrealized derivative financial instrument loss and an impairment charge that was driven by lower production and increased cellhouse capital expenditures,” said Paul Einarson, Chief Executive Officer of Canadian Electrolytic Zinc Limited, Noranda Income Fund’s Manager.

“As previously announced, because of the accelerated deterioration of cellhouse operating conditions, we have temporarily shut down operations to proceed with a proactive cell repair program aimed at mitigating risk while we finalize and implement plans to replace all cells. Two weeks into the shutdown, the team is making progress repairing previously identified damaged cells and undertaking a cell-by-cell integrity assessment to determine if further cell repairs will be necessary. At this time, the shutdown is expected to last an additional three to four weeks, subject to change should additional cells need to be repaired or should other issues be discovered,” concluded Mr. Einarson.

Cellhouse Maintenance Shutdown and Revitalization Project
On October 19, 2022, the Fund announced a maintenance shutdown to perform identified cell repairs in the cellhouse as well as a cell-by-cell integrity assessment to determine whether additional repairs are necessary. While the Fund believes that this extensive cell repair program will contribute to stabilizing near term cellhouse operating conditions, it will not fully address the underlying issues impacting operating conditions. Evaluations undertaken thus far have led to the conclusion that a replacement of all cells in the cellhouse will be necessary to stabilize and improve operating conditions, in addition to the planned crane replacements. A careful review to assess potential replacement options, related capital investment requirements and financing options is ongoing. The cost of a full cell and crane replacement is currently estimated to be approximately $100 million and replacement would not commence before 2024. The timeline may be influenced by supply chain constraints and by securing appropriate financing. More updates will follow once a decision on the plan for long-term cellhouse revitalization has been finalized.